Browse studies

Find your next paid study

27,333 recruiting studies available now

Prospective Case Series of Intestinal and Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

The goal of this prospective phase 2 study is to assess the efficacy and safety of intestinal or multivisceral transplantation for participants with PMP not am…

Secondary Malignant Neoplasm of RetroperitoneumSecondary Malignant Neoplasm of PeritoneumPseudomyxoma Peritonei

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Case Comprehensive Cancer CenterNCT06084780

Observational

Thermogenic Responses to Fasting and Overfeeding in Women: a Potential Mechanism Contributing to Postmenopausal Weight Gain

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The…

Obesity

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT06610162

Phase 1

A Phase 1 Study of the Antibody-Radionuclide Conjugate SLR-108 for Positron Emission Tomography Imaging in Subjects With Metastatic Solid Tumors

This is a Phase 1 study evaluating the feasibility of using SLR-108 for positron-emission tomography (PET) imaging of metastatic solid tumors.

Metastatic Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Solve TherapeuticsNCT07728942

Phase 1

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Pulmonary Diseases

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells f…

Pulmonary DiseaseAsthmaChronic Obstructive Pulmonary Disease

Estimated

~$150 – $3,000

Actual pay is set by the research site.

The Foundation for Orthopaedics and Regenerative MedicineNCT05147688

Phase 2

Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Background: Identifying medium- and high-risk prostate cancer early may allow for treatments to work. But identification can be hard. Researchers want to see …

Localized Prostate Cancer

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05155046

Phase 3

A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients With BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy (EvoPAR-Prostate02).

The purpose of the study is to demonstrate superiority of Saruparib (AZD5305) relative to placebo added to a standard radiation therapy (RT) + androgen depriva…

Prostate Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06952803

Observational

Handheld Point of Care Electro-Diagnostic Device

There are currently several products offering POC EEG, intended to be deployed on each patient individually and continuously. The investigators propose studyin…

Neurologic Findings

Estimated

~$10 – $750

Actual pay is set by the research site.

Indiana UniversityNCT07223827

Phase 4

A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment

This will be a global Phase IV, open-label, randomised study to evaluate the safety and tolerability of acalabrutinib (monotherapy, 100 mg orally \[po\], twice…

Chronic Lymphocytic LeukaemiaModerate to Severe Cardiac Impairment

Estimated

~$25 – $1,500

Actual pay is set by the research site.

AstraZenecaNCT06651970

Phase 2

A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase …

End Stage Kidney Disease

Estimated

~$75 – $3,000

Actual pay is set by the research site.

CSL BehringNCT05485961

Observational

Development of a T2D-Specific, Virtually-Delivered Disordered Eating Prevention Intervention - Diabetes Body Project 2

The purpose of this study is to test the feasibility and effectiveness of an eating disorder prevention program specifically targeted for women with type 2 dia…

Eating DisordersType 2 Diabetes

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Joslin Diabetes CenterNCT07468188

Phase 3

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

The goal of this study is to learn how GLP-1 receptor agonist therapy affects muscle and bone health in older females over age 65 with type 2 diabetes. The ma…

Diabetes Mellitus, Type 2

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Emory UniversityNCT07428746

Observational

Assessment of Adolescent and Young Adult Vaccine Confidence and Missed Opportunities for Vaccination in the Mountain West (VACCINE CONFIDENCE - WEST): A Randomized Tailored Vaccine Messaging Intervention

his study will evaluate whether tailored vaccine messaging improves vaccination-related outcomes among parents and caregivers of adolescents. Participants will…

Vaccine ConfidenceAdolescent VaccinationVaccine Uptake

Estimated

~$10 – $750

Actual pay is set by the research site.

University of UtahNCT07878442